Welcome to our dedicated page for Welltower SEC filings (Ticker: WELL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Welltower Inc. (NYSE: WELL) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a publicly traded S&P 500 real estate company focused on residential wellness and healthcare infrastructure, Welltower uses its filings to report on capital markets activity, portfolio transactions, governance decisions, and financial performance.
Welltower’s Form 8-K filings frequently describe material events such as at-the-market equity distribution agreements, registration of common shares issued as consideration in property acquisitions, and prospectus supplements related to shares that may be issued upon redemption of units in its operating partnership, Welltower OP LLC. These filings also cover announcements of quarterly earnings releases and supplemental information packages, which include details on net income, funds from operations (FFO), normalized FFO, net operating income (NOI), and same store NOI (SSNOI).
Other SEC documents, including automatic shelf registration statements on Form S-3 and related prospectus supplements, outline how Welltower may issue equity and debt securities, including common stock, guarantees of notes, and other instruments. Filings also describe long-term executive compensation and alignment programs, such as the Ten Year Executive Continuity and Alignment Program, which is structured around performance-based units in the operating partnership and long-term total shareholder return and market capitalization goals.
On Stock Titan, users can review these SEC filings alongside AI-powered summaries that explain key terms and implications. Real-time updates from EDGAR ensure that new 8-Ks, registration statements, and other reports are available as they are filed. Investors can also focus on disclosures related to capital structure, note guarantees, equity issuance programs, and governance arrangements that shape Welltower’s long-term strategy in seniors and wellness housing.
Welltower Inc. reported Q3 2025 results showing broad growth and portfolio repositioning. Revenue rose to $2,685,692,000 from $2,055,663,000 a year ago, with net income attributable to common stockholders of $280,559,000 and diluted EPS of $0.41. Operating cash flow reached $2,227,348,000 for the nine months.
The company accelerated capital deployment and recycling. Year‑to‑date, it disbursed $4,040,936,000 for acquisitions and $736,288,000 for capital improvements, while signing a definitive agreement to sell 319 outpatient medical properties for approximately $7,200,000,000, expected to close in tranches through mid‑2026. At September 30, 2025, assets held for sale totaled $5,091,216,000 with expected gross proceeds of about $7,306,583,000. Subsequent agreements in October include U.K. portfolios of approximately £5.2 billion and approximately £1.2 billion. Q3 dividends were $0.74 per share. As of October 24, 2025, shares outstanding were 686,328,043.
Welltower Inc. (WELL) adopted a Ten‑Year Executive Continuity and Alignment Program as its primary pay framework, featuring long‑term LTIP Units and minimal cash pay. Effective October 30, 2025, named executives receive LTIP Units; from 2026–2035 they forgo other compensation aside from $110,000 annual base salary.
Half of each award is time‑based; half is performance‑based over a five‑year period from October 6, 2025 to October 5, 2030. For the CEO, target totals 4,970,293 LTIP Units and maximum 8,698,012. Performance vesting ties to market capitalization milestones from $10,000,000,000 up to $100,000,000,000 and to relative TSR versus three indices, subject to a positive TSR requirement.
Redeemability begins no earlier than October 31, 2030 and then monthly through September 30, 2035. The company states shares available under the 2022 Plan are sufficient at target but not at maximum; exceeding target may require shareholder approval to increase the share reserve.
Welltower Inc. furnished an 8-K announcing it issued a press release with operating results for the third quarter ended September 30, 2025 and a separate press release on certain transactions closed or under contract to close across the U.K. and U.S.
Copies of the earnings press release, a supplemental information package, and the transactions press release were furnished as Exhibits 99.1, 99.2, and 99.3 and are incorporated by reference. The disclosures under Items 2.02 and 7.01, including these exhibits, are being furnished and are not deemed filed under the Exchange Act.
Dennis G. Lopez, a director of Welltower Inc. (WELL), received 73 shares of common stock on 08/21/2025 as dividend equivalent rights settled in stock. The transaction shows a per-share price of $166.94 and the filing reports the reporting person’s beneficial ownership following the transaction as 16,555.57 shares. The filing’s explanatory note clarifies these shares represent dividend equivalents accrued on outstanding deferred stock units that may only be settled in common stock. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Lopez on 08/25/2025.
Welltower Inc. (NYSE: WELL) has filed a Rule 424(b)(7) prospectus supplement covering the resale of 949,412 previously issued common shares by Maverick Purchaser II LLC. The shares were issued as non-cash consideration in a recently completed property acquisition (the “Transaction”). Welltower will receive no proceeds from any sales; all net proceeds accrue to the selling stockholder. Sales may occur on the NYSE, in private transactions or via other permitted methods at prevailing or negotiated prices.
The filing reiterates Welltower’s profile as a healthcare-focused REIT with a global portfolio of 1,500+ senior living and outpatient properties and outlines standard risk factors (market volatility, capital access, regulatory changes, dividend limitations, REIT qualification tests). It also details anti-takeover provisions and ownership limits (9.8% cap) designed to preserve REIT status. As of 25 Jul 2025, Welltower had 667.9 million shares outstanding; the offered block represents ~0.14% of total shares, implying minimal dilution risk but potential short-term trading overhang. The common stock last traded at $158.29 on 28 Jul 2025.
FAQ
What is the current stock price of Welltower (WELL)?
What is the market cap of Welltower (WELL)?
